Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Associate Professor Ana Domingos reviews the identification of the hormone leptin and explores its significance in the function of immune cells in obesity.

 

Leptin resistance is the main culprit of common obesity. - Prof Domingos

Associate Professor Ana Domingos trained in the laboratory of our inaugural Sir Hans Krebs Award Lecture speaker, Dr Jeffrey Friedman, where the hormone leptin, a key regulator of fat mass, was discovered. In a new review published in Nature Reviews Immunology, Prof Domingos reports how leptin was first identified and the significant advances this discovery has enabled for research into obesity.

 

The discovery of leptin represented a paradigm shift at a time when mechanistic models of obesity were restricted to voluntary control of food intake and exercise. - Prof Domingos

Prof Domingos goes on to suggest that immunometabolic models of obesity would benefit from an increased focus on the contribution of leptin.

The full review "Leptin: a missing piece in the immunometabolism puzzle" is available to read in Nature Reviews Immunology.

 

Similar stories

Leducq-funded transatlantic network set to pioneer new diagnosis and treatment of heart disease

Professor David Paterson, in collaboration with the UCLA’s Professor Kalyanam Shivkumar, has been awarded a prestigious Leducq International Network of Excellence Program Award of $8 million (£6.3M) to set up a major new transatlantic network linking world leading researchers from the USA and Europe to develop ‘Bioelectronics for neurocardiology diagnosis and therapeutics’.